Stock Events

Stock Events

Tenax Therapeutics 

$16
0
+$1.64+11.42% Wednesday 07:55

Statistics

Day High
16
Day Low
14.36
52W High
-
52W Low
-
Volume
30
Avg. Volume
-
Mkt Cap
99.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q3 2025
Q4 2025
Next
-0.41
-0.38
-0.35
-0.31
Expected EPS
-0.396667
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-35.2MNet Income

Analyst Ratings

$34.50Average Price Target
The highest estimate is 35.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TENX.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biopharmaceutical company that competes in the development of cardiovascular drugs, similar to Tenax Therapeutics' focus.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that has a broad portfolio including cardiovascular drugs, directly competing with Tenax Therapeutics.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in the discovery, development, and manufacture of healthcare products including treatments for cardiovascular diseases, making it a competitor.
Merck
MRK
Mkt Cap214.76B
Merck operates in the pharmaceutical industry with a focus on cardiovascular diseases among others, competing with Tenax Therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including for cardiovascular diseases.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies in areas including cardiovascular diseases.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company with a range of products for complex and serious health conditions, including cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for cardiovascular diseases.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a healthcare company that develops and sells a wide range of products, including pharmaceuticals for cardiovascular health.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly is a global healthcare leader that works to discover and bring life-changing medicines to those who need them, with efforts in cardiovascular disease treatments.

About

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Show more...
CEO
ISIN
US88032L6056

Listings

XNAS
US
TENX
F
DE
YBO0.F
BOATS
BOATS
TENX.BOATS

0 Comments

Share your thoughts

FAQ

What is Tenax Therapeutics stock price today?▼
The current price of TENX.BOATS is $16 USD — it has increased by +11.42% in the past 24 hours. Watch Tenax Therapeutics stock price performance more closely on the chart.
What is Tenax Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tenax Therapeutics stocks are traded under the ticker TENX.BOATS.
What is Tenax Therapeutics market cap?▼
Today Tenax Therapeutics has the market capitalization of 99.89M
When is the next Tenax Therapeutics earnings date?▼
Tenax Therapeutics is going to release the next earnings report on May 19, 2026.
What were Tenax Therapeutics earnings last quarter?▼
TENX.BOATS earnings for the last quarter are -0.38 USD per share, whereas the estimation was -0.41 USD resulting in a +8.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tenax Therapeutics revenue for the last year?▼
Tenax Therapeutics revenue for the last year amounts to 0 USD.
What is Tenax Therapeutics net income for the last year?▼
TENX.BOATS net income for the last year is -35.2M USD.
When did Tenax Therapeutics complete a stock split?▼
Tenax Therapeutics has not had any recent stock splits.